Nanoveu fills first antiviral product sales orders, on track for first revenue in quarter three
The company is confident of strong demand for its products, with orders from customers across the US, UK, Asia and Australia.
Company
Nanoveu Ltd
ASX:NVU
EMASS, a Nanoveu business, is a fabless semiconductor company specialising in ultra-low-power, AI-enabled system-on-chip (SoC) solutions for always-on sensing and intelligent processing at the edge. Its ECS-DoT architecture enables real-time AI inference at milliwatt-level power, supporting next-generation applications across drones, wearables, hearables, smart devices, industrial IoT, robotics and autonomous systems.
30 stories · page 2 of 2
Nanoveu shares up following Singapore antiviral protection distribution agreement
The agreement will expand the application of Nanoveu’s antiviral technology through the sale of antiviral gym and home fitness equipment to the Asia-Pacific region.
Nanoveu to deploy phone screen protector laminating machines in Thailand
An agreement has been signed with a subsidiary of major Thai telecommunications network AIS to deploy Customskins laminating machines.
Nanoveu in strong position for antiviral product launch following specialist sales team appointment
D360 will assist in online retail sales as well as go-to-market services for the US, Canada and UK regions
Nanoveu higher as antiviral phone protectors are approved by TGA
The Australian Therapeutics Goods Administration has registered the technology as a Class I Medical Device.
Nanoveu shares surge as antiviral technology independently validated against human coronaviruses
In just 30 minutes the number of viable or infectious coronavirus particles was reduced by 99.99%.
Nanoveu shares soar after testing validates smartphone screen antiviral technology against coronaviruses
The antimicrobial technology demonstrated to be effective against a coronavirus strain emerging from mice, which is a surrogate for human coronaviruses.
Nanoveu enhances smartphone suite with anti-viral and anti-reflective technologies
The company has developed antiviral nanotechnology to deliver enhanced protection from viruses and bacteria for smartphone and tablet users.
Nanoveu attracts interest with antiviral products for smartphones
The company’s nanotechnology is being developed to protect phone and tablet users from viruses and bacteria, including coronavirus.
Nanoveu share price doubles after commencing testing of smartphone screen protectors to fight coronaviruses
Initial testing has demonstrated Nanoveu’s technology to be effective against viruses and bacteria.